secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inhibrx Biosciences, Inc. (INBX)
CIK:        0002007919
Form:       8-K
Filed at:   2026-06-03T20:02:12+00:00
Accession:  0002007919-26-000030
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Inhibrx shareholders elect Forsyth and Manhard as directors, ratify BDO USA
---------------------------------------------------------------------------

- Quorum of 11,541,232 shares (79% of outstanding) present at June 3, 2026 annual meeting.
- Douglas G. Forsyth elected Class II director with 7,608,469 votes for, 1,463,474 withheld.
- Kimberly Manhard elected Class II director with 9,035,097 votes for, 36,846 withheld.
- Ratification of BDO USA as auditor passed: 11,510,478 for, 30,347 against, 407 abstained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2007919/000200791926000030/0002007919-26-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2007919/000200791926000030/inhibrx-20260603.htm
  HTML page:      https://secwatch.observer/filing/0002007919-26-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer